Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # FDA Peptide Reclassification 2026: What Researchers Want FDA IS REPORTEDLY EXPECTED TO LIFT RESTRICTION ON PEPTIDES NYT Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy